Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

Clinical trial NCT02223208 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02223208
Sponsor: Fondazione Italiana Linfomi - ETS
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphomas (PTCL)PTCL-NOS Angioimmunoblastic T-cell Lymphoma (AITL)ALK- Anaplastic Large Cell Lymphoma (ALCL)Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin

Start date: 2014-09-01
Primary completion: 2020-10-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.